Page last updated: 2024-08-26

fulvestrant and methotrexate

fulvestrant has been researched along with methotrexate in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bowen, D; Davis, JH; DeSoto, JA; Fryar, EB; Hawkins, M; Southerland, WM	1
Eucker, J; Kühnl, A; Possinger, K	1
Adamoli, L; Aurilio, G; Botteri, E; Colleoni, M; Cullurà, D; Curigliano, G; Esposito, A; Goldhirsch, A; Minchella, I; Munzone, E; Nolè, F; Sciandivasci, A	1

Reviews

1 review(s) available for fulvestrant and methotrexate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for fulvestrant and methotrexate

Article	Year
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report. The breast journal, 2012, Volume: 18, Issue:5 Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Drug Administration Schedule; Estradiol; Female; Fulvestrant; Humans; Methotrexate; Middle Aged; Postmenopause; Receptors, Estrogen; Retrospective Studies	2012

Article

Year

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

The breast journal, 2012, Volume: 18, Issue:5

Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Drug Administration Schedule; Estradiol; Female; Fulvestrant; Humans; Methotrexate; Middle Aged; Postmenopause; Receptors, Estrogen; Retrospective Studies

2012

Other Studies

3 other study(ies) available for fulvestrant and methotrexate

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
The interaction of the steroidal antagonist faslodex and methotrexate. Cellular and molecular biology (Noisy-le-Grand, France), 2003, Volume: 49, Issue:7 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Division; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Methotrexate; Tumor Cells, Cultured	2003
[Systemic therapy of male breast cancer]. Zentralblatt fur Chirurgie, 2007, Volume: 132, Issue:5 Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Combined Modality Therapy; Cyclophosphamide; Estradiol; Fluorouracil; Fulvestrant; Humans; Male; Methotrexate; Orchiectomy; Randomized Controlled Trials as Topic; Survival Rate; Tamoxifen; Treatment Outcome	2007